HIMS
PUTS ▼Hims & Hers Health, Inc.
$27.68
-6.71%delayed
News – · Trend ▼ · below put trigger ▼
Expected move (1d)
▼ $25.88to$29.48 ▲
ATR ±$1.80 (+6.50%)Implied ±$2.35 (+8.49%)
Entry Reference
Price / prev close$27.68 / $29.67
Day range$26.68 – $28.75
52-wk range$13.74 – $48.34(40%)
Volume vs avg1.01×
ATR (14d)$1.80
MA 8 / 21$28.53 / $28.94
MA 50 / 200$29.04 / $27.03
Call ▲ / Put ▼ trigger$30.09 / $29.25
+1 / +2 ATR$29.48 / $31.28
-1 / -2 ATR$25.88 / $24.08
Support: 27.31 26.73 26.33
Resistance: 29.82 30.29 31.03
Near-the-money contracts
exp 2026-11-06Calls
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 26.5 | $1.79 | 74% | 0.69 | -0.08 | 15 |
| 27 | $1.52 | 76% | 0.62 | -0.08 | 683 |
| 27.5 | $1.26 | 77% | 0.55 | -0.09 | 111 |
| 28 | $1.01 | 76% | 0.48 | -0.09 | 722 |
| 28.5 | $0.81 | 76% | 0.41 | -0.09 | 300 |
| 29 | $0.68 | 78% | 0.35 | -0.08 | 1553 |
Puts
| Strike | Mark | IV | Δ | θ/day | OI |
|---|---|---|---|---|---|
| 26.5 | $0.66 | 77% | -0.31 | -0.08 | 89 |
| 27 | $0.84 | 76% | -0.38 | -0.08 | 1407 |
| 27.5 | $1.09 | 77% | -0.45 | -0.09 | 545 |
| 28 | $1.36 | 78% | -0.52 | -0.09 | 840 |
| 28.5 | $1.67 | 78% | -0.59 | -0.08 | 221 |
| 29 | $2.00 | 79% | -0.65 | -0.08 | 287 |
Δ = delta (≈ probability ITM), θ/day = daily time decay, IV = implied vol. Greeks computed via Black-Scholes from Yahoo IV.
Recent news
- Hims & Hers Health, Inc. (HIMS) Gains As Market Dips: What You Should Know1d ago
- Teladoc Soars 11% on Q3 Beat and Raised Outlook as “Insurance Revenue Exceeded Our Expectations”1d ago
- Eli Lilly Soars 5% as Mounjaro and Zepbound Demand Drives $5.5 Billion Guidance Raise1d ago
- Eli Lilly Jumps 8% as Strong Quarter Lifts Revenue Outlook; Novo Nordisk Ticks Up, Viking Therapeutics Eases2d ago
- HIMS Stock Jumps 5% After HHS Temporarily Clears Compounding Of Six Peptides2d ago
- Hims & Hers Jumped 6% as RFK Jr.’s HHS Uses “Enforcement Discretion” to Open Peptide Compounding2d ago
- Hims Stock Surges After RFK Jr. Eases Access To Unapproved Peptides2d ago
- Can Hims & Hers Stock Fall 30%?3d ago
- U.S. Department Of Health And Human Services Announces Availability Of Enforcement Discretion Policy Regarding 503a Compounding Using Certain Peptide Bulk Drug Substances; Will Not Enforce Against Pharmacies, Federal Facilities Or Physicians Compounding Drugs Using Peptide Bulk Substances Pending Rulemaking; Interim Policy Permits Peptide Compounding Pending Final Rulemaking On 503a Bulk Drug Substances List3d ago
- Investors Heavily Search Hims & Hers Health, Inc. (HIMS): Here is What You Need to Know4d ago
- 1 unprofitable stock for long-term investors and 2 we avoid4d ago
- What Bears Saw Before Hims & Hers Health Slid6d ago
Reference data only. Not a recommendation. Greeks and expected-move figures are estimates, not certainties. You confirm all entries and contracts in TradingView and Charles Schwab.